PTP
ABUS icon

Platform Technology Partners’s Arbutus Biopharma ABUS Stock Holding History

Platform Technology Partners’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$53K Buy
+15,000
New +$52.5K 0.03% 225

Other funds holding ABUS

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Platform Technology Partners's ABUS Position: Q4 2020 in Review

Platform Technology Partners opened a new position in Arbutus Biopharma (ABUS) in Q4 2020: 15,000 shares worth $53K. The stake represents 0.03% of the portfolio and ranks #225 among its holdings.

80 funds tracked by Wall St. Rank hold ABUS as of Q4 2020.

  • Platform Technology Partners held 15,000 shares of Arbutus Biopharma worth $53K as of Q4 2020.
  • Arbutus Biopharma was a new Platform Technology Partners position in Q4 2020.
  • Arbutus Biopharma made up 0.03% of Platform Technology Partners's portfolio in Q4 2020, its #225 holding.
  • 80 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2020.

Based on Platform Technology Partners's 13F filing for Q4 2020, filed 9 Feb 2021.